ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd (GLMD)

3,8498
-0,0602
( -1,54% )
Aktualisiert: 19:00:03

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
3,8498
Gebot
3,80
Fragen
3,84
Volumen
46.372
3,80 Tagesbereich 3,95
2,73 52-Wochen-Bereich 23,80
Marktkapitalisierung
Handelsende
3,91
Handelsbeginn
3,87
Letzte Trade
1
@
3.84
Letzter Handelszeitpunkt
19:00:27
Finanzvolumen
US$ 179.158
VWAP
3,8635
Durchschnittliches Volumen (3 Mio.)
3.172.510
Ausgegebene Aktien
643.690
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,36
Gewinn pro Aktie (EPS)
-10,74
Erlöse
-
Nettogewinn
-6,91M

Über Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Tel Aviv, Center, Isr
Gegründet
-
Galmed Pharmaceuticals Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GLMD. The last closing price for Galmed Pharmaceuticals was US$3,91. Over the last year, Galmed Pharmaceuticals shares have traded in a share price range of US$ 2,73 to US$ 23,80.

Galmed Pharmaceuticals currently has 643.690 shares in issue. The market capitalisation of Galmed Pharmaceuticals is US$2,52 million. Galmed Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.36.

GLMD Neueste Nachrichten

Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology

Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology PR Newswire TEL AVIV, Israel, Sept. 25, 2024 The paper re-iterates the significant anti-fibrotic effect of Aramchol...

Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases

Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases PR Newswire TEL AVIV, Israel, Sept. 19, 2024 Aramchol is the most clinically advanced, first-in-class...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.2002-23.76633663375.055.23.81964494.18324854CS
40.21986.055096418733.6323.83.56816468112.39242906CS
120.0230.6010243545523.826823.82.73317251011.41304302CS
26-1.0102-20.78600823054.8623.82.73151949111.25513985CS
52-1.3678-26.21511806195.217623.82.7385760210.50228326CS
156-494.7502-99.2278780586498.6563.42.7338228940.95110322CS
260-671.1502-99.42965925936751328.42.73299132200.87491983CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
JTAIJet AI Inc
US$ 0,19
(105,18%)
627,68M
BLMZBloomZ Inc
US$ 1,205
(68,48%)
60,08M
XHGXChange TED Inc
US$ 0,274501
(53,35%)
199,89M
MLGOMicroAlgo Inc
US$ 0,3414
(35,48%)
93,64M
WHLRWheeler Real Estate Investment Trust Inc
US$ 13,00
(33,20%)
5,2M
GRTSGritstone bio Inc
US$ 0,071
(-64,21%)
72,59M
MNTSMomentus Inc
US$ 0,7722
(-27,15%)
21,81M
CLIKClick Holdings Ltd
US$ 1,95
(-26,14%)
511,84k
TXG10x Genomics Inc
US$ 15,6375
(-24,86%)
9,43M
INHDInno Holdings Inc
US$ 5,1488
(-24,28%)
74,21k
JTAIJet AI Inc
US$ 0,19
(105,18%)
636,45M
XHGXChange TED Inc
US$ 0,274501
(53,35%)
204,44M
NVDANVIDIA Corporation
US$ 134,3809
(1,30%)
149,69M
MLGOMicroAlgo Inc
US$ 0,3414
(35,48%)
94,81M
SQQQProShares UltraPro Short QQQ
US$ 7,1899
(0,28%)
91,72M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock